CNY 24.44
(-0.33%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 4.82 Billion | -1.51 Billion | 1.76 Billion | 3.69 Billion | 2.73 Billion | -101.59 Million |
Net Income | 1.47 Billion | 862.87 Million | 574.16 Million | 550.69 Million | 147.81 Million | 91.83 Million |
Depreciation & Amortization | 1.3 Billion | 1.17 Billion | 1.08 Billion | 1.12 Billion | 1.07 Billion | 997.19 Million |
Deferred income taxes | -229.82 Million | -19.08 Million | -188.14 Million | -201.58 Million | -117.78 Million | -52.4 Million |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 2.21 Billion | -3.04 Billion | 336.35 Million | 1.35 Billion | 1.51 Billion | -1.03 Billion |
Other non-cash items | 426.11 Million | -511.97 Million | -240.14 Million | 660.22 Million | 319.24 Thousand | -152.17 Million |
Investing Cash Flow | -1.38 Billion | -89.14 Million | -78.63 Million | -1.91 Billion | -1.36 Billion | -1.13 Billion |
Investments in PPE | -1.29 Billion | -1.38 Billion | -1.16 Billion | -1.41 Billion | -1.61 Billion | -1.38 Billion |
Acquisitions | 112.09 Million | 191.1 Million | 84.61 Million | 32.67 Million | 3.88 Million | 2.77 Million |
Investment purchases | -500 Million | -100 Million | -1.8 Billion | -16.1 Billion | -9.2 Billion | -10.35 Billion |
Sales/Maturities of investments | 300 Million | 201.52 Million | 2.51 Billion | 15.38 Billion | 9.24 Billion | 10.37 Billion |
Other Investing Activities | -88.7 Thousand | 998.76 Million | 290.98 Million | 186.55 Million | 200.47 Million | 228.2 Million |
Financing Cash Flow | -241.05 Million | 581.85 Million | -3.23 Billion | 399.11 Million | -50.71 Million | -2.28 Billion |
Debt repayment | -172.2 Million | -3.9 Billion | -1.7 Billion | -1.8 Billion | -200.45 Million | -433.83 Thousand |
Dividends payments | -366 Million | -229.61 Million | -3 Billion | -60.42 Million | -34.52 Million | -2.27 Billion |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -11.93 Million | 4.71 Billion | 1.46 Billion | 2.27 Billion | 185.19 Million | -1.25 Million |
Accounts receivables | 1.24 Billion | -2.21 Billion | 196.01 Million | -1.11 Billion | 225.97 Million | -215.94 Million |
Accounts payables | 639.52 Million | -521.14 Million | 413.37 Million | 2.86 Billion | 894.96 Million | -457.84 Million |
Inventory | 356.81 Million | -324.84 Million | -134.81 Million | -325.78 Million | 464.07 Million | -289.82 Million |
Other working capital | -20.85 Million | 17.34 Million | -138.21 Million | -64.2 Million | -68.7 Million | -748.62 Million |
Cash at beginning of period | 8.6 Billion | 9.56 Billion | 11.12 Billion | 8.93 Billion | 7.61 Billion | 11.13 Billion |
Cash at end of period | 11.83 Billion | 8.54 Billion | 9.56 Billion | 11.12 Billion | 8.93 Billion | 7.61 Billion |
Capital Expenditure | -1.29 Billion | -1.38 Billion | -1.16 Billion | -1.41 Billion | -1.61 Billion | -1.38 Billion |
Effect of forex changes on cash | 22.25 Million | - | - | - | - | - |
Net cash flow / Change in cash | 3.22 Billion | -1.02 Billion | -1.55 Billion | 2.18 Billion | 1.32 Billion | -3.52 Billion |
Free Cash Flow | 3.53 Billion | -2.89 Billion | 590.78 Million | 2.28 Billion | 1.12 Billion | -1.48 Billion |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 270.61 Million | 413.11 Million | 482.36 Million | 466.14 Million | 1.47 Billion | 280.06 Million |
Depreciation & Amortization | - | 363.78 Million | 363.78 Million | 345.05 Million | 1.3 Billion | -589.8 Million |
Deferred income taxes | - | - | - | - | -229.82 Million | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | 1.62 Billion | 2.21 Billion | -1 Billion |
Other non-cash items | 597.59 Million | -413.11 Million | -1.09 Billion | -29.57 Million | 426.11 Million | 2.03 Billion |
Investing Cash Flow | -327 Million | -472.04 Million | -216.7 Million | -532.83 Million | -1.38 Billion | -236.52 Million |
Investments in PPE | -384.82 Million | -546.89 Million | -285.68 Million | -361.67 Million | -1.29 Billion | -236.58 Million |
Acquisitions | 17.4 Million | 3.04 Million | 5.96 Million | 837.6 Thousand | 112.09 Million | 24.9 Million |
Investment purchases | -200 Million | -200 Million | -200 Million | -200 Million | -500 Million | -200 Million |
Sales/Maturities of investments | 201.21 Million | 205.46 Million | 201.32 Million | 200 Million | 300 Million | 106.38 Million |
Other Investing Activities | 56.6 Million | 66.34 Million | 61.68 Million | -172 Million | -88.7 Thousand | 68.76 Million |
Financing Cash Flow | -604.08 Million | 85.1 Million | -908.51 Million | 173.5 Million | -241.05 Million | -82.18 Million |
Debt repayment | -1.8 Million | -94.59 Million | -901.28 Million | -3.32 Million | -172.2 Million | -1 Billion |
Dividends payments | -594.69 Million | -1.36 Million | -3.08 Million | -3.66 Million | -366 Million | -370.73 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -7.58 Million | -8.12 Million | -4.14 Million | 578.16 Million | -11.93 Million | 1.28 Billion |
Accounts receivables | - | - | - | 1.24 Billion | 1.24 Billion | -694.35 Million |
Accounts payables | - | - | - | - | 639.52 Million | -41.04 Million |
Inventory | - | - | - | 356.81 Million | 356.81 Million | -308.14 Million |
Other working capital | - | - | - | 25.58 Million | -20.85 Million | 41.04 Million |
Cash at beginning of period | 10.96 Billion | 10 Billion | 11.74 Billion | 10.01 Billion | 8.6 Billion | 9.25 Billion |
Cash at end of period | 11.02 Billion | 10.96 Billion | 10 Billion | 11.83 Billion | 11.83 Billion | 9.69 Billion |
Capital Expenditure | -384.82 Million | -546.89 Million | -285.68 Million | -361.67 Million | -1.29 Billion | -236.58 Million |
Effect of forex changes on cash | - | - | - | -233.75 Million | 22.25 Million | 35.21 Million |
Net cash flow / Change in cash | 61.95 Million | 960.67 Million | -1.73 Billion | 1.81 Billion | 3.22 Billion | 439.72 Million |
Free Cash Flow | 483.38 Million | 806.18 Million | -898.64 Million | 2.04 Billion | 3.53 Billion | 486.63 Million |
SILVERTUC
MPU
INFE
GMET
HESTERBIO
BAYERCROP